In the last post, I talked about the "new" cancer in my hip, and how that signaled the current drug had run its course.
That was before the second opinion.
Earlier this week, M.A. , Jim II (he's finally home from Indy for a few weeks!!!) and I met with an oncologist at the Dana Farber Institute to get some additional perspective on how to best address the recent developments. We expected a biopsy, and a change in treatment.
After reviewing the scans and the history of the cancer, he concluded that while there may be some new cancerous activity, it's advancing very slowly. In the grand scheme, we've taken 50 steps forward since the original diagnosis, and recently, only one step back.
We're still way ahead of the bad guys.
Therefore, stay on the current meds for as long as we can, to buy some time for the development and testing of the next phase chemo drugs. At some point, we'll need to go there. Things are not bad enough at this time, to warrant the move.
We'll go back for scans every two to three months to gauge the growth of the new cancer. We won't move to another drug until we see real measurable growth. This approach, he explained, is very low risk, and puts time on our side.
Or, to bring it back to the bullpen metaphor, the current pitcher still has plenty of pitches left in his arm. There's no statistically valid reason to pull him from the game yet. We'll watch him closely, and pull him when he's closer to getting into real trouble. For now, let's let him stay on the mound, because we have a solid lead.
And that's the big picture that really matters.